Compare

Danaher vs Labcorp

MonkScore ranges and fundamentals, side by side

Key facts

Danaher and Labcorp: key facts

  • In fiscal 2025, Danaher Corporation reported revenue of $24.6B and net income of $3.6B.
  • In fiscal 2025, Labcorp Holdings Inc. reported revenue of $14.0B and net income of $876.5M.
  • Danaher Corporation's revenue fell 4.4% a year from fiscal 2021 to fiscal 2025.
  • Labcorp Holdings Inc.'s revenue grew 1.5% a year from fiscal 2021 to fiscal 2025.
  • Danaher Corporation's free cash flow was positive in 5 of the 5 fiscal years from 2021 to 2025.
  • Labcorp Holdings Inc.'s free cash flow was positive in 5 of the 5 fiscal years from 2021 to 2025.
  • In the twelve months to 25 September 2026, Danaher Corporation reported revenue of $25.6B and net income of $4.3B.
  • In the twelve months to 30 September 2026, Labcorp Holdings Inc. reported revenue of $14.6B and net income of $1.0B.

Side by side

Danaher and Labcorp, side by side

Each figure is in the company's reporting currency, with its fiscal year or the date of its last report.

FigureDanaher CorporationNYSE:DHRLabcorp Holdings Inc.NYSE:LH
MonkScore
MonkScore range30–39as of November 202650–59as of November 2026
Sector rank428 of 628 in Healthcare297 of 628 in Healthcare
How this score is madeDisclaimer
Profile
SectorHealthcareHealthcare
IndustryMedical - Diagnostics & ResearchMedical - Diagnostics & Research
Latest fiscal year
Revenue$24.6BFY 2025$14.0BFY 2025
Net income$3.6BFY 2025$876.5MFY 2025
Free cash flow$5.3BFY 2025$1.2BFY 2025
Operating cash flow$6.4BFY 2025$1.6BFY 2025
Total debt$18.4BFY 2025$7.2BFY 2025
Cash$4.6BFY 2025$532.3MFY 2025
Last 12 months
Revenue$25.6Bto 25 September 2026$14.6Bto 30 September 2026
Net income$4.3Bto 25 September 2026$1.0Bto 30 September 2026
Free cash flow$5.7Bto 25 September 2026$1.3Bto 30 September 2026
Operating cash flow$6.9Bto 25 September 2026$1.8Bto 30 September 2026
Total debt$26.5Bto 25 September 2026$6.8Bto 30 September 2026
Cash$5.7Bto 25 September 2026$261.8Mto 30 September 2026

MonkStreet provides research, not investment advice.